Related Experiment Video
Updated: Jul 9, 2026

12:19
Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
IL-6 and PGE2 release by human osteoblasts on implant materials
C Schmidt1, G Steinbach, R Decking
1Institute of Orthopaedic Research and Biomechanics, RKU University of Ulm, Helmholtzstr. 14, 89081, Ulm, Germany. carla.schmidt@medizin.uni-ulm.de
Biomaterials
|July 11, 2003
Summary
Orthopaedic implant materials did not significantly affect the release of interleukin-6 (IL-6) and prostaglandin E(2) (PGE(2)) from human osteoblasts. The released mediators were likely insufficient to cause bone resorption and implant loosening.
Area of Science:
- Biomaterials Science
- Orthopaedic Surgery
- Immunology
Background:
- Orthopaedic implant loosening is a significant clinical challenge.
- Particle-induced inflammation, involving macrophages and osteoblasts, is hypothesized to cause bone resorption and implant failure.
- Key mediators implicated include interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and prostaglandin E(2) (PGE(2)).
Purpose of the Study:
- To compare the in vitro ability of clinically relevant orthopaedic implant materials to induce IL-6 and PGE(2) release from human osteoblasts.
- To investigate whether material composition influences osteoblast mediator release independently of macrophage activation.
Main Methods:
- Primary human osteoblasts were cultured with stainless steel, cobalt-chromium alloy (CoCrMo), commercially pure titanium (cpTi), Ti-6Al-7Nb, and Ti-6Al-4V samples.
- Cells were also cultured with a plastic control.
- Supernatants were collected after 12 and 24 hours to measure IL-6 and PGE(2) concentrations.
Main Results:
- Osteoblasts actively secreted IL-6 and PGE(2) in response to all tested materials and the plastic control.
- No significant differences in IL-6 or PGE(2) release were observed among the different implant materials.
- The measured mediator levels were comparable to literature values for osteoblasts cultured on plastic and lower than levels induced by direct particle stimulation or inflammatory cytokines (IL-1, TNF-alpha).
Conclusions:
- The tested orthopaedic implant materials, with similar surface roughness, did not significantly influence IL-6 and PGE(2) release from human osteoblasts.
- The released concentrations of PGE(2) were likely insufficient to activate osteoclasts and induce osteolysis.
- The role of the measured IL-6 concentrations in promoting osteolytic activity remains unclear due to conflicting literature.
- Material composition differences did not significantly impact mediator release under these experimental conditions.
Related Concept Videos
Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

